![methyl 4-[(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (2E)-but-2…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F340094-1-piperazinecarboxylic-acid-4-2-34-dichlorophenyl-acetyl-3-1-pyrrolidinylmethyl-methyl-ester-2e-2-butenedioate-1-1.webp&w=3840&q=75)
CAS 126766-32-3: methyl 4-[(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (2E)-but-2-enedioate
Formula:C19H25Cl2N3O3·C4H4O4
InChI:InChI=1S/C19H25Cl2N3O3.C4H4O4/c1-27-19(26)23-8-9-24(15(13-23)12-22-6-2-3-7-22)18(25)11-14-4-5-16(20)17(21)10-14;5-3(6)1-2-4(7)8/h4-5,10,15H,2-3,6-9,11-13H2,1H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
InChI key:InChIKey=ABTNETSDXZBJTE-WLHGVMLRSA-N
SMILES:C(CC1=CC(Cl)=C(Cl)C=C1)(=O)N2C(CN3CCCC3)CN(C(OC)=O)CC2.C(=C/C(O)=O)\C(O)=O
Synonyms:- 1-Piperazinecarboxylic acid, 4-[(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-, methyl ester, (2E)-2-butenedioate (1:1)
- 1-Piperazinecarboxylic acid, 4-[(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-, methyl ester, (E)-2-butenedioate (1:1)
- 1-Piperazinecarboxylic acid, 4-[2-(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-, methyl ester, (2E)-2-butenedioate (1:1)
- Gr 89696
- Methyl 4-[(3,4-dichlorophenyl)acetyl]-3-(pyrrolidin-1-ylmethyl)piperazine-1-carboxylate (2E)-but-2-enedioate (1:1)
Sort by
Found 7 products.
GR 89696
CAS:Controlled ProductFormula:C19H25Cl2N3O3·C4H4O4Color and Shape:NeatMolecular weight:530.398GR 89696 fumarate
CAS:GR 89696 fumarate is a highly selective κ2 opioid receptor agonist (IC50 = 0.04nM) with anti-pruritchy, anti-injury and neuroprotective effects.Formula:C23H29Cl2N3O7Purity:99.19%Color and Shape:SolidMolecular weight:530.41-Piperazinecarboxylic acid, 4-[2-(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-, methyl ester, (2E)-2-butenedioate (1:1)
CAS:Formula:C23H29Cl2N3O7Purity:98%Color and Shape:SolidMolecular weight:530.3983GR 89696 fumarate salt
CAS:GR 89696 is a kappa-opioid receptor agonist that is a racemic mixture of the two enantiomers, S and R. It has high affinity for the human kappa-opioid receptor, with values of 500 nM and 100 nM for the S and R enantiomers, respectively. GR 89696 has been shown to produce antinociception in experimental animals. This effect was blocked by pretreatment with the δ-opioid antagonist naltrindole, but not by pretreatment with the κ-opioid antagonist norbinaltorphimine or the κ/δ-opioid antagonist pentazocine. The drug also inhibits rotarod performance in mice at low doses, which may be due to its sedative effect. GR 89696 has been shown to inhibit bone cancer cell growth in vitro and in vivo without inducing significant toxicity in healthy cells. The drug also showed efficacy againstFormula:C19H25Cl2N3O3·C4H4O4Purity:Min. 95%Molecular weight:530.4 g/molMethyl 4-(2-(3,4-Dichlorophenyl)Acetyl)-3-(Pyrrolidin-1-Ylmethyl)Piperazine-1-Carboxylate Fumarate
CAS:Methyl 4-(2-(3,4-Dichlorophenyl)Acetyl)-3-(Pyrrolidin-1-Ylmethyl)Piperazine-1-Carboxylate FumaratePurity:98%Molecular weight:530.4g/mol
![1-Piperazinecarboxylic acid, 4-[2-(3,4-dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-, methyl es…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA000T7X.jpg&w=3840&q=75)
